Saibal Kar, MD
Enriched profileDirector of Structural Heart Disease Interventions and Clinical Research, Los Robles Health System; Clinical Professor of Medicine, David Geffen School of Medicine at UCLA · Los Robles Health System
Saibal Kar is Director of Structural Heart Disease Interventions and Clinical Research, Los Robles Health System; Clinical Professor of Medicine, David Geffen School of Medicine at UCLA at Los Robles Health System. OpenAlex indexes 415 publications with 31,870 citations (h-index 78); ClinicalTrials.gov lists 20 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Interventional Cardiology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Saibal Kar, MD, is Director of Structural Heart Disease Interventions and Clinical Research, Los Robles Health System. The public record shows 415 publications with 31,870 citations (h-index 78), centered on Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors, Atrial Fibrillation Management and Outcomes. It also documents an investigator role on 20 registered clinical trials, industry payments reported by 47 companies.
- Most recent indexed publication: 2026 · Journal of the American Heart Association
- Top research focus: Cardiac Valve Diseases and Treatments
- 20 registered trials on ClinicalTrials.gov
- Open Payments reporting from 47 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 195.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 20 registered studies on ClinicalTrials.gov. The most recent:
- Abbott Cephea Mitral Valve Disease Registry
Sponsor: Abbott Medical Devices
Industry payments
Updated 27 Aug 2026
47 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202569 payments$26,741openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202574 payments$14,561openpaymentsdata.cms.gov ↗
- W. L. Gore & Associates, Inc.Program year202510 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.5%Angiotensin receptor-neprilysin inhibitor (ARNI)20.4%Entresto100%Part D<11 patientsBeta blocker19.7%Carvedilol59%Metoprolol Succinate41%Part D<11 patientsMetabolism & gastrointestinal
30.7%SGLT2 inhibitor22.6%Farxiga100%Part D≥13 patientsPotassium supplement8%Potassium Chloride100%Part D<11 patientsBlood & clotting
13.9%P2Y12 inhibitor13.9%Clopidogrel100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinical, Functional, and Quality-of-Life Outcomes After Contemporary Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation in the Very Elderly.
Journal of the American Heart Association
Article2026 - Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies.
Circulation. Cardiovascular interventions
Article2026
Most-cited works
by citation count (OpenAlex)- 01Transcatheter Mitral-Valve Repair in Patients with Heart Failure2,926 citations2018
- 02Percutaneous Repair or Surgery for Mitral Regurgitation2,154 citations2011
- 03
- 04Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale1,060 citations2012
- 055-Year Outcomes After Left Atrial Appendage Closure996 citations2017
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
scai.org/about-us/scai-staff-listing/saibal-kar-md-fscai
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →scai.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cacvi.org ↗
- Residency in Internal Medicine and Fellowship in Cardiology
Postgraduate Institute of Medical Education and Research, Chandigarh, India
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cacvi.org ↗ - Interventional Cardiology Fellowship
Epworth Hospital, Melbourne, Australia
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cacvi.org ↗ - Repeat Internal Medicine Residency
West Los Angeles VA Medical Center; Cardiology and Interventional Cardiology Fellowship, Cedars-Sinai Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cacvi.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →citoday.com ↗
- Director of Structural Heart Disease Interventions and Clinical Research
Los Robles Health System
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cacvi.org ↗
Awards & honors
honors on the public record- FACC
Fellow of the American College of Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cacvi.org ↗ - FSCAI
Fellow of the Society for Cardiovascular Angiography and Interventions
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scai.org ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cacvi.org ↗ - Interventional Cardiologist
Adventist Health (Bakersfield, CA location)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.adventisthealth.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- The Murmur Pod
episode with Dr. Saibal Kar and Dr. Thomas Waggoner discussing the Champion AF trial data
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - "An Interview With Saibal Kar, MD"
Cardiac Interventions Today (print/web interview)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →citoday.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology